Vinflunine in Hormone Refractory Prostate Cancer (HRPC)

Clinical trial NCT00545766 · COMPLETED

Trial details

NCT number: NCT00545766
Sponsor: SCRI Development Innovations, LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2007-05-01
Primary completion: 2008-01-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.